Steelhead Capital Management provides investment advice to private funds, focusing on early-stage and growth-stage biotech and medical device companies. Steelhead investigates, analyzes, structures, and negotiates potential investments for the funds, monitors their performance, and advises on disposition opportunities. Steelhead typically establishes separate investment vehicles to invest in a business on a deal-by-deal basis. Steelhead does not provide investment advice directly to the limited partners in the funds.
Fee Structure
Steelhead Capital Management manages investments for private funds. Investors in the funds are charged an investment management fee based on the aggregate capital commitments, invested capital, or adjusted capital contributions. The specific fee is negotiated between Steelhead and each fund and is detailed in the fund's offering documents. Steelhead expects these fees to be deducted from the capital called from each fund investor's committed capital on a quarterly basis in advance.